Abstract
In industrialized societies, the most frequent forms of cancers are derived from epithelia of the gastrointestinal and urogenitary tract, mammary ducts, and bronchi. Despite recent progress in early detection and surgical therapy of these tumors, cancer-related mortality has remained high. The major reason for this disturbing discrepancy is that occult dissemination of viable malignant cells can occur at an eprly stage of tumor growth (Riethmüller and Johnson 1992). This implies that the acquisition of at least some characteristics of metastatic behavior can occur prior to attainment of the unrestrained growth observed in fully developed tumors. In this context, it is important to consider that tumorigenesis and metastasis development are not necessarily the result of the same genetic changes (Fidler and Radinsky 1990; Liotta et al. 1991).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baum M (1977) The curability of breast cancer. In: Stall BA (ed) Breast cancer management. Heinemann, London, pp 3–13
Berger U, Bettelheim R, Mansi JL, Easton D, Coombes RC, Neville AM (1988) The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Am J Clin Pathol 90: 1–6
Bezwoda WR, Lewis D, Livini N (1986) Bone marrow involvement in an aplastic small-cell lung cancer. Cancer 58: 1762–1765
Bonnheim DC, Petrelli NJ, Herrera L, Walsh D, Mittelman A (1986) Osseous metastases from colorectal carcinoma. Am J Surg 151: 457–459
Bos IL (1989) Ras oncogenes in human cancer: a review. Cancer Res 49: 4682–4689
Braun S, Pantel K (1996) Biological characteristics of human micrometastatic carcinoma cells. In: Gunthert U, Birchmeier W (eds) Attempts to understand metastasis formation. I Metastasis-related molecules. Springer, Berlin Heidelberg New York (Current topics in microbiology and immunology, vol, 213/1, pp 163–177
Brugger W, Bross KJ, Glatt M et al (1994) Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83: 636
Burkhardt R, Frisch B, Kettner G (1980) The clinical study of micrometastatic cancer by bone biopsy. Bull Cancer 67: 291–305
Canon JL, Humblet Y, Lebacq-Verheyden, AM, Mannouriez P, Bazin H, Rodhain J, Prignot J, Symann M (1988) Immunodetection of small-cell lung cancer metastases in bone marrow using three monoclonal antibodies. Eur J Cancer Clin Oncol 24: 147–150
Chen ZL, Perez S, Holmes EC, Wang HJ, Coulson WF, Wen DR, Cochran AJ (1993) Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst 85: 493–498
Cote RJ, Rosen PP, Hakes TB, Sedira M, Bazinet M, Kinne DW, Old LJ, Osborne MP (1988) Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease. Am J Surg Pathol 12: 333–340
Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP (1991) Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9: 1749–1756
Cutait R, Alves VA, Lopes LC, Cutait DE, Borges JL, Singer J, Da Silva JH, Goffi FS (1991) Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 34: 917–920
Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS (1994) Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12: 475–482
De Mascarel I, Bonichon F, Coindre JM, Trojani M (1992) Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: réévaluation with longer follow up. Br J Cancer 66: 523–527
Deguchi T, Doi T, Ehara H, Ito S, Takahashi Y, Nishino Y, Fujihiro S, Kawamura T, Komeda H, Horie M, Kaji H, Shimokawa K, Tanala T, Kawada Y (1993) Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 53: 5350–5354
Diel IJ, Kaufmann M, Goerner R, Costa SD, Kaul S, Bastert G (1992) Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol 10: 1534–1539
Dillman R (1994) Antibodies as cytotoxic therapy. J Clin Oncol 12: 1497–1515
Fidler I J, Radinsky R (1990) Genetic control of cancer metastasis. J Natl Cancer Inst 82: 166–168
Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M (1994) Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 12: 725–729
Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Carol F, Freeman GJ, Ritz J, Nadler LM (1991) Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation of B-cell lymphoma. N Engl J Med 325: 1525–1533
Gross HJ, Verwer B, Houck D, Hoffmann RA, Recktenwald D (1995) Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10–7. Proc Natl Acad Sci USA 92: 537–541
Harbeck N, Untch M, Pache L, Eiermann W (1994) Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br J Cancer 69: 566–571
Harris CC, Hollstein M (1993) Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329: 1318–1327
Hayashi N, Ito I, Yanagisawa A, Kato Y, Nakamori S, Imaoka S, Watanabe H, Nakamura K (1995) Genetic diagnosis of lymph-node metastases in colorectal cancer. Lancet 345: 1257–1259
Henderson BE, Ross RK, Pike MC (1991) Toward the primary prevention of cancer. Science 254: 1131–1137
Herlyn DM, Steplewski Z, Herlyn MF, Koprowski H (1980) Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. Cancer Res 40: 717–721
Hermanek P, Henson DE, Hutter RV, Sobin LH (1993) TNM supplement. Springer, Berlin Heidelberg New York
Hoechtlen-Vollmar W, Gruber R, Bodenmüller H, Lindemann F, Schlimok G, Pantel K, Riethmüller G (1995) Occult epithelial tumor cells detected in bone marrow by an enzyme immunoassay specific for cytokeratin 19 (submitted)
Humblet Y, Canon JL, Sekhavat M, Feyens AM, Manouvriez P, Lebacq-Verhyden AM, Bazin H, Prignot J, Symann M (1988) Detection of small-cell lung cancer bone marrow metastases by immunofluorescence. Pathobiology 36: 25–28
Israeli RS, Miller WH Jr., Su SL, Powell CT, Fair WR, Samedi DS, Huryk RF, De Blasio A, Edwards ET, Wise GJ, Heston WDW (1994) Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res 54: 6306–6310
Jain RK (1990) delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J Natl Cancer Inst 81: 570–576
Jauch K, Heiss MM, Grützner U, Funke I, Pantel K, Babic R, Eissner HJ, Riethmüller G, Schildberg FW (1995) The prognostic significance of early disseminated tumor cells in bone marrow of patients with gastric cancer, (submitted)
Juhl H, Stritzel M, Wroblewski A, Henne-Bruns D, Kremer B, Schmiegel W, Neumaier M, Wagener C, Schreiber HW, Kalthoff H (1994) Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer 57: 330–335
Kamby K, Guldhammer B, Vejborg I, Rossing N, Dirksen H, Daugaard S, Mouridsen HT (1987) The presence of tumor cells in bone marrow at the time of first recurrence of breast cancer. Cancer 60: 1306–1312
Koga S, Takebayashi M, Kaibara N, Nishidoi H, Kimura O, Kawasumi H, Makino M (1987) Pathological characterization of gastric cancer that develop hematogenous recurrence, with special reference to the site of recurrence. J Surg Oncol 36: 239–242
Kovarik J, Lauerová L, Rejthar A, Bártek J (1989) Keratin typing in screening bone marrows for carcinoma cells. Cytotechnology S78: 79
Krook JE, Mgertel CG, Gunderson LL et al (1991) Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324: 709–715
Lebacq-Verheyden AM, Neirynck A, Ravoet AM, Humblet Y, Oie H, Linnoila I, Gazdar AF, Minna JD, Symann M (1988) Monoclonal antibodies for the vitro detection of small-cell lung cancer metastases in human bone marrow. Eur J Cancer Clin Oncol 24: 137–145
Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmüller G (1992) Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340: 685–689
Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327–336
Manegold C, Krempien B, Kaufmann M, Schwechheimer K, Schettler G (1988) The value of bone marrow examination for tumor staging in breast cancer. J Cancer Res Clin Oncol. 114: 425–428
Mansi JL, Berger U, Easton D, McDonnell T, Redding WH, Gazet JC, McKinna A, Powles TJ, Coombes RC (1987) Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br Med J 295: 1093–1096
Mansi JL, Berger U, Wilson P, Shearer R, Coombes RC (1988) Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques. J Urol 139: 545–548
Mansi JL, Berger V, McDonnell T, Pople A, Rayter Z, Gazet JC, Coombes RC (1989) The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol 7: 445–449
Mansi JL, Easton D, Berger U, Gazet JC, Ford HT, Dearnaley D, Coombes RC (1991) Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years’ follow-up. Eur J Cancer 27: 1552–1555
Moertel CG, Fleming TR, MacDonald JS et al (1991) Levamisole and fluoroacil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322: 352–358
Molino A, Colombatti M, Bonetti F, Zardini M, Pasini F, Perini A, Pelosi G, Tridente G, Veneri D, Cetto GL (1991) A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow. Cancer 67: 1033–1036
Moreno JG, Croce CM, Fischer R, Monne M, Vihko P, Mulholland SG, Gomella LG (1992) Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 52: 6110–6112
Mountain CF (1986) A new international staging system for lung cancer. Chest 89 [Suppl]: 225S-233S
Oberneder R, Riesenberg R, Kriegmair M, Bitzer U, Klammert R, Schneede P, Hofstetter A, Riethmüller G, Pantel K (1994a) Immunocytochemical detection and phenotypic characterization of micrometastatic tumour cells in bone marow of patients with prostate cancer. Urol Res 22: 3–8
Oberneder R, Kriegmair M, Pantel K, Staudte S, Hofstetter A, Riethmüller G (1994b) Prognostic relevance of micrometastatic tumor cells in bone marrow of patients with genitourinary tract tumors. J Urol 151: 413A
Osborne MP, Wong GY, Asina Sh, Old LJ, Cote RJ, Rosen PP (1991) Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow. Cancer Res 51: 2706–2709
Pantel K, Izbicki JR, Passlick B, Angstwurm M, Häussinger K, Thetter O, Riethmüller G (1996) Incidence and prognostic significance of isolated tumour cells detected in bone marrow of non-small cell lung cancer patients without overt metastases. Lancet (in press)
Pantel K, Schlimok G, Braun S, Kutter D, Schaller G, Funke I, Izbicki J, Riethmüller G (1993a) Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 85: 1419–1424
Pantel K, Koprowski H, Riethmüller G (1993b) Conference on cancer micrometastasis: biology, methodology and clinical significance. Int J Oncol 3: 1019–1022
Pantel K, Schlimok G, Angstwurm M, Weckermann C, Schmaus W, Gath H, Passlick B, Izbicki J, Riethmüller G (1994) Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 3: 165–173
Pantel K, Aignherr C, Köllermann J, Caprano J, Riethmüller G, Köllermann MW (1995a) Immunocytochemical detection of isolated tumor cells in bone marrow of patients with untreated stage C prostatic cancer. Eur J Cancer 31A: 1627–1632
Pantel K, Schlimok G, Angstwurm M, Passlick B, Izbicki JR, Johnson JP, Riethmüller G (1995b) Early metastasis of human solid tumors: expression of cell adhesion molecules. In: Ciba Foundation Symposium (eds) Cell adhesion and human disease. Wiley, Chichester, pp 157–173
Passlick B, Izbicki JR, Kubuschok B, Nathrath W, Thetter O, Pichlmeier U, Schweiberer L, Riethmüller G, Pantel K (1994) Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small cell lung cancer. J Clin Oncol 12: 1827–1832
Persson MA (1993) Combinatorial libraries. Int Rev Immunol 10: 153–63
Porro G, Menard S, Tagliabue E, Orefice S, Salvadori B, Squicciarini P, Andreola S, Rilke F, Colnaghi Ml (1988) Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patients. Cancer 61: 2407–2411
Redding HW, Coombes RC, Monagham P, Clink HMD, Imrie SF, Dearnaley DP, Ormerod MG, Sloane JP, Gazet JC, Powels TJ, Neville AM (1983) Detection of micrometases in patients with primary breast cancer. Lancet ii: 1271–1274
Ridell B, Landys K (1979) Incidence and histopathology of metastases of mammary carcinoma in biopsies from the posterior iliac creast. Cancer 44: 1782–1788
Riesenberg R, Orberneder R, Kriegmair M, Epp M, Bitzer U, Hofstetter A, Braun S, Riethmüller G, Pantel K (1993) Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumor cells. Histochemistry 99: 61–66
Riethmuller G, Johnson JP (1992) Monoclonal antibodies in the detection and therapy of micro-metastatic epithelial cancer. Curr Opin Immunol 4: 647–655
Riethmuller G, Schneider-Gadicke E, Johnson JP (1993) Monoclonal antibodies in cancer therapy. Curr Opin Immunol 5: 732–739
Riethmuller G, Schneider-Gadicke E, Schlimok G, Schmiegel W, Raab R, Hoffken K, Gruber R, Pichlmaier H, Hirche H, Pichlmayr R, Buggisch P, Witte J, and the German Cancer Aid 17–1A
Study Group (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes’ C colorectal carcinoma. Lancet 343: 1177–1183
Schlimok G, Funke I, Holzmann B, Gottlinger HG, Schmidt G, Hauser H, Swierkot S, Warnecke HH, Schneider B, Koprowski H, Riethmuller G (1987) Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17–1A monoclonal antibodies. Proc Natl Acad Sci USA 84: 8672–8676
Schlimok G, Funke I, Bock S, Schweiberer B, Witte J, Riethmuller G (1990) Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance. J Clin Oncol 8: 831–837
Schlimok G, Funke I, Pantel K, Strobel F, Lindemann F, Witte J, Riethmuller G (1991) Micrometastatic tumor cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer 27: 1461–1465
Schlimok G, Lindemann F, Holzmann K, Witte J, Pantel K, Riethmuller G (1994) Prognostic significance of tumor cells detected in bone marrow of breast cancer patients: a multivariate analysis. Onkologie 17 [Suppl 2]: 128
Schlimok G, Pantel K, Loibner H, Fackler-Schwalbe I, Riethmuller G (1995) Individual metastatic tumor cells in bone marrow of cancer patients reduced by intravenously administered monoclonal antibody: towards a novel surrogate marker for adjuvant therapy. Eur J Cancer 31A: 1799–1803
Schoenfeld A, Luqmani Y, Smith D, O’Reilly S, Shousha S, Sinnett HD, Coombes RC (1994) Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 54: 2986–2990
Scholz D, Lubeck M, Loibner H, Steplewski Z, Koprowski H (1991) Biological activity in the human system of isotype variants of oligosaccharide Y-specific murine monoclonal antibodies. Cancer Immunol Immunother 33: 153–157
Seiden MV, Kantoff PW, Krithivas K, Propert K, Bryant M, Haltom E, Gaynes L, Kaplan I, Bubley G, De Wolf W, Sklar J (1994) Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol 12: 2634–2639
Stahel RA, Mabry M, Skarin AT, Speak J, Bernal SD (1985) Detection of bone marrow metastasis in small cell lung cancer by monoclonal antibody. J Clin Oncol 3: 455–461
Tada M, Omata M, Kawai Sh, Saisho H, Ohto M, Saiki RK, Sninsky JJ (1993) Detection of ras gene mutations in pancreatic juice peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 53: 2472–2474
Talbot RW, Irvine B, Jass JR, Dowd GS, Northover JM (1989) Bone metastases carcinoma of the rectum: a clinical and pathological review. Eur J Surg Oncol 15: 449–452
Tavian D, De Petro G, Colombi M, Portolani N, Giulini SM, Gardella R, Barlati S (1994) RT-PCR detection of fibronectin EDA+ and EDB+ mRNA isoforms: molecular markers for hepatocellular carcinoma. Int J Cancer 56: 820–825
Traweek ST, Liu J, Battifora H (1993) Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. Am J Pathol 142: 1111–1118
Weiss L, Grundmann E, Torhorst J, Hartveit F, Moberg I, Eder M, Fenoglio Preiser C, Napier J, Home CH, Lopez MJ (1986) Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 150: 195–203
Welch JP, Donaldson GA (1979) The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 189: 496–502
Williamson RA, Burioni R, Sanna PP et al (1993) Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries. Proc Natl Acad Sci USA 90: 4141–4145
Wood DP, Banks ER, Humphries S, McRoberts JW, Rangnekar M, Lexington KY (1994) Identification of micrometastases in patients with prostate cancer. J Urol 151: 303A
Zippelius A, Honald G, Kufer P, Riethmuller G, Pantel K (1995) Detection of isolated carcinoma cells in bone marrow by RT-PCR. J Cancer Res Clin Oncol 121 [Suppl 2]: A5
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Pantel, K., Riethmüller, G. (1996). Micrometastasis Detection and Treatment with Monoclonal Antibodies. In: Günthert, U., Schlag, P.M., Birchmeier, W. (eds) Attempts to Understand Metastasis Formation III. Current Topics in Microbiology and Immunology, vol 213/3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80071-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-80071-9_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80073-3
Online ISBN: 978-3-642-80071-9
eBook Packages: Springer Book Archive